The significance of steatotic liver disease in metabolic syndrome-related diseases

The significance of steatotic liver disease in metabolic syndrome-related diseases - The significance of steatotic liver disease in metabolic syndrome-related diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055046

Enrollment

800

Registered

2024-08-01

Start date

2024-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

steatotic liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases in which the presence or absence of steatotic liver (diagnosed by ultrasound examination) was diagnosed among the same health checkup recipients (first year, seven years later)

Exclusion criteria

Exclusion criteria: Those who have not undergone a medical checkup in the first year or seven years after the examination, or have not undergone an ultrasound examination in either year

Design outcomes

Primary

Measure	Time frame
To investigate the significance of steatotic liver disease for the onset of metabolic syndrome-related diseases in non-metabolic syndrome-related disease patients	—

Secondary

Measure	Time frame
To explore the effect of improving steatotic liver disease on metabolic syndrome-related diseases in patients with fatty liver	—

Countries

Japan

Contacts

Public ContactYoshihiro Kamada

Osaka University Graduate School of Medicine Department of Advanced Metabolic Hepatology

ykamada@sahs.med.osaka-u.ac.jp0668792561

Outcome results